Hematologic Malignancy
Plasma Cell Neoplasm
CI-CAN-00006438Explore in graph →
HematologicNon-malignant831 active trials25 approved drugs26 evidence items
Loading cancer entity…
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00006438Explore in graph →
Clinical trials
3,420 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05190653 | Early Integration of Palliative and Supportive Care in Cellular Therapy(PALS_CT) | unknown | N/A | 152 | Alberta Health Services, CalgaryOTHER | 1 | Jul 31, 2024 | clinicaltrials |
| NCT05536154 | Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies | unknown | N/A | 68 | The Affiliated People's Hospital of Ningbo UniversityOTHER_GOV | 1 | Mar 19, 2024 |
| clinicaltrials |
| NCT05697913 | Efficacy of Response-adapted Treatment in Patients With Multiple Myeloma Candidates for Bone Marrow Transplantation | unknown | N/A | 66 | Hospital Galdakao-UsansoloOTHER_GOV | 0 | Mar 6, 2024 | clinicaltrials |
| NCT06258096 | LI-TASTE Study: Light for Taste(LI-TASTE) | unknown | N/A | 52 | Academic Centre for Dentistry in AmsterdamOTHER | 0 | Feb 14, 2024 | clinicaltrials |
| NCT06203145 | A Clinical Study on the Whole-course Management (BCD-KPD-AutoHSCT) Scheme for Patients With RIMM | unknown | N/A | 30 | Peking University First HospitalOTHER | 1 | Jan 12, 2024 | clinicaltrials |
| NCT05308875 | Efficacy and Safety Evaluation of PD1-BCMA-CART | unknown | N/A | 9 | Bioray LaboratoriesINDUSTRY | 1 | Jan 5, 2024 | clinicaltrials |
| NCT04663100 | Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence | unknown | N/A | 30 | University of TennesseeOTHER | 1 | Dec 4, 2023 | clinicaltrials |
| NCT05378971 | Clinical Research of Pomalidomide Maintenance Therapy for Primary Multiple Myeloma | unknown | N/A | 15 | LanZhou UniversityOTHER | 1 | Oct 4, 2023 | clinicaltrials |
| NCT06060080 | Efficacy and Safety of PEG-rhG-CSF Injection for Neutrophil Reconstitution Following AHSCT in Lymphoma/Multiple Myeloma | unknown | N/A | 7 | Yao LiuOTHER | 1 | Sep 29, 2023 | clinicaltrials |
| NCT05995808 | Cyclin D1 as a Prognostic Factor in Multiple Myeloma and Its Association With the Immunological Prognostic Factor PDL1 and Clinical and Biochemical Lab Tests | unknown | N/A | 30 | Sohag UniversityOTHER | 0 | Aug 16, 2023 | clinicaltrials |
| NCT05964270 | Telemonitoring Among Patients With Multiple Myeloma(ITUMM) | unknown | N/A | 150 | IsalaOTHER | 1 | Jul 27, 2023 | clinicaltrials |
| NCT05893693 | Assess the Safety and Efficacy of CT0594CP Cells in Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia | unknown | N/A | 12 | Aibin Liang，MD，Ph.D.OTHER | 1 | Jun 8, 2023 | clinicaltrials |
| NCT05822037 | CT0594CP CAR-T Cells in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia | unknown | N/A | 6 | The First Affiliated Hospital of Soochow UniversityOTHER | 1 | Apr 20, 2023 | clinicaltrials |
| NCT05619861 | CAR-T Cells in the Treatment of Malignant Hematological Tumors | unknown | N/A | 20 | Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY | 1 | Nov 17, 2022 | clinicaltrials |
| NCT05548686 | Benefits of Adapted Physical Activity for Chronic Osteoarticular Pain in Patients With Multiple Myeloma(ALGOMYELOMOV) | unknown | N/A | 15 | University Hospital, CaenOTHER | 0 | Sep 21, 2022 | clinicaltrials |
| NCT05448404 | A Head-to-head Comparative Study of 18F-PSMA-1007 PET/CT and 18F-FDG PET/CT Imaging in Multiple Myeloma | unknown | N/A | 30 | First Hospital of China Medical UniversityOTHER | 1 | Jul 8, 2022 | clinicaltrials |
| NCT05381077 | Evaluation of Whole Body Examination by MRI Integrating the "Zero Time Eco" Sequence (ZTE, Pseudo-CT) for the Detection of Bone Lesions in Multiple Myeloma: Comparison With Pet / CT and Whole Body Scanner(MM-ZTE) | unknown | N/A | 30 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | May 19, 2022 | clinicaltrials |
| NCT03574454 | Machine Learning in Myeloma Response(MALIMAR) | unknown | N/A | 50 | Royal Marsden NHS Foundation TrustOTHER | 1 | Jan 11, 2022 | clinicaltrials |
| NCT05184595 | Cost-Utility Analysis of Home-based Versus Hospital-based Chemotherapy in Multiple Myeloma: Case of Carfilzomib(ADHOMY2) | unknown | N/A | 52 | Central Hospital, Nancy, FranceOTHER | 0 | Jan 11, 2022 | clinicaltrials |
| NCT05088330 | A Study to Access of Daratumumab Combined With VRD in the Treatment of Patients With Standard-risk Newly Diagnosed MM | unknown | N/A | 76 | The First Affiliated Hospital of Soochow UniversityOTHER | 0 | Oct 21, 2021 | clinicaltrials |
| NCT04320420 | Feasibility of an Adapted Physical Activity Program for Patients Treated With an Autograft (APA²)(APA²) | unknown | N/A | 57 | WepromOTHER | 1 | Oct 8, 2021 | clinicaltrials |
| NCT04665076 | Multicenter Clinical Study on the Safety and Effectiveness of CAR-T in the Treatment of Relapsed/Refractory Plasma Cell Tumors | unknown | N/A | 60 | Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY | 1 | Dec 11, 2020 | clinicaltrials |
| NCT03380039 | Clinical Study of CAR-BCMA T Cells in Patients With Refractory or Relapsed Multiple Myeloma | unknown | N/A | 6 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Oct 12, 2020 | clinicaltrials |
| NCT03302403 | Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors | unknown | N/A | 18 | Kang YUOTHER | 1 | Oct 8, 2020 | clinicaltrials |
| NCT04447573 | Immunotherapy With BCMA CAR-T Cells in Treating Patients With Relapsed or Refractory Multiple Myeloma | unknown | N/A | 20 | Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY | 1 | Sep 29, 2020 | clinicaltrials |
| NCT04496011 | Effect of the Cycloergometer in Patients Undergoing Hematopoietic Stem Cell Transplantation | unknown | N/A | 30 | Federal University of Health Science of Porto AlegreOTHER | 1 | Aug 3, 2020 | clinicaltrials |
| NCT04376957 | Pilot Study of an Oral Chemotherapy Teaching Tool to Improve Adherence in Patients With Multiple Myeloma | unknown | N/A | 60 | Hamilton Health Sciences CorporationOTHER | 0 | May 6, 2020 | clinicaltrials |
| NCT04212858 | Amplification of Zinc Finger Protein 217 Gene in Multiple Myeloma | unknown | N/A | 100 | Assiut UniversityOTHER | 0 | Dec 30, 2019 | clinicaltrials |
| NCT04008888 | a Clinical Trial of Efficacy and Safety of the Holistic Treatment of Young High-risk Multiple Myeloma Patients | unknown | N/A | 50 | Institute of Hematology & Blood Diseases Hospital, ChinaOTHER | 1 | Jul 5, 2019 | clinicaltrials |
| NCT03704597 | Cryotherapy Against Oral Mucositis After High-dose Melphalan | unknown | N/A | 100 | Sahlgrenska University HospitalOTHER | 0 | Oct 15, 2018 | clinicaltrials |
| NCT03556748 | WB-EMS and Nutrition in Patients With Hematological Malignancies | unknown | N/A | 40 | University of Erlangen-Nürnberg Medical SchoolOTHER | 1 | Jun 14, 2018 | clinicaltrials |
| NCT03373526 | Effects of Aerobic Training and Inspiratory Muscle Training in Patients During Hematopoietic Stem Cell Transplantation | unknown | N/A | 50 | Daniel Godoy MartinezOTHER | 1 | Dec 18, 2017 | clinicaltrials |
| NCT02087657 | Pilot Study Exploring the Use of Hyperbaric Oxygen in Autologous Peripheral Blood Stem Cell Transplantation(Auto-HBO) | unknown | N/A | 20 | University of Kansas Medical CenterOTHER | 1 | Feb 14, 2017 | clinicaltrials |
| NCT02572596 | Comparing Intermediate-dose CTX+ G-CSF Plus or Not rhTPO for PB CD34+ Cells Mobilization in MM Patients | unknown | N/A | 200 | Wang GuorongOTHER | 1 | Feb 9, 2017 | clinicaltrials |
| NCT02981199 | Microtransplantation Versus Auto-SCT in ≥PR Multiple Myeloma Patients | unknown | N/A | 80 | Chen WenmingOTHER | 1 | Dec 16, 2016 | clinicaltrials |
| NCT02184897 | Pharmacokinetic and Pharmacodynamic Study of Lenograstim for Hematopoietic Stem Cell Mobilization | unknown | N/A | 24 | Asan Medical CenterOTHER | 1 | Jul 26, 2016 | clinicaltrials |
| NCT01892852 | Acupuncture for Chemotherapy-induced Peripheral Neuropathy | unknown | N/A | 36 | Pusan National University HospitalOTHER | 1 | Jul 17, 2013 | clinicaltrials |
| NCT01859234 | 89Zr-bevacizumab PET Scan in Patients With Relapsing Multiple Myeloma | unknown | N/A | 20 | University Medical Center GroningenOTHER | 1 | May 21, 2013 | clinicaltrials |
| NCT01572688 | Safety and Efficacy Study of High Dose Melphalan to Treat Multiple Myeloma(MM) | unknown | N/A | 60 | Shandong Lanjin Pharmaceuticals Co.,LtdINDUSTRY | 1 | Aug 2, 2012 | clinicaltrials |
| NCT01042717 | Study of the Best Timing for Plerixafor in Autologous Hematopoietic Stem Cell Collection | unknown | N/A | 10 | Shi, Patricia, M.D.INDIV | 1 | Sep 27, 2011 | clinicaltrials |
| NCT00166855 | Clinical Implication of Bone Marrow Perfusion Patterns Imaged by Dynamic MRI in Multiple Myeloma | unknown | N/A | 40 | National Taiwan University HospitalOTHER | 1 | Nov 24, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Jul 31, 2024source: clinicaltrials